Washington University School of Medicine: Head and Neck Neoplasms trials

The registry lists 21 Head and Neck Neoplasms studies with Washington University School of Medicine as lead sponsor. 5 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 1 3Phase 2 8No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck SurgeryRecruitingNCT07848841Not applicable
• CCR2 PET Imaging Head and Neck Squamous Cell CarcinomaRecruitingNCT07659678Phase 2
• Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)Not yet recruitingNCT07552558Phase 1/2
• Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenRecruitingNCT06904365
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck CancerTerminatedNCT04217057Phase 1Results posted
• Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)CompletedNCT02573493Phase 2Results posted
• Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell CarcinomaCompletedNCT02296684Phase 2Results posted
• Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck CancerCompletedNCT01566435Phase 2Results posted
• Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
• Ramucirumab and Pembrolizumab vs Pembrolizumab Monotherapy in PD-L1 Positive Head and Neck Squamous-Cell CarcinomaActive, not recruitingNCT05980000Phase 2
• Online Peri-operative Education Program for Patients Undergoing Major Head & Neck SurgeryWithdrawnNCT05954676Not applicable
• Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)CompletedNCT05789316Not applicable
• Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT05678348Early Phase 1
• Palliative Expeditiously Adaptive Quad Shot Radiation Therapy (PEAQ-RT)CompletedNCT04379505Not applicable
• Fluorescence Imaging in Head and Neck CancerTerminatedNCT03297957Not applicable
• Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT02270814Phase 2
• Effectiveness in Head and Neck Cancer Detection Using Positron Emission Tomography (PET) Insert DeviceWithdrawnNCT01133262
• Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1CompletedNCT00968656Phase 1
• A Feasibility Study of Adaptive Intensity-Modulated Radiation TherapyTerminatedNCT00608751Early Phase 1
• Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck CancerCompletedNCT00167908Phase 2